Charles Schwab’s Moleculin Biotech MBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,440
Closed -$38.8K 3574
2022
Q4
$38.8K Buy
+2,440
New +$38.8K ﹤0.01% 3409
2022
Q3
Sell
-2,097
Closed -$46K 3533
2022
Q2
$46K Buy
2,097
+750
+56% +$16.5K ﹤0.01% 3402
2022
Q1
$36K Hold
1,347
﹤0.01% 3563
2021
Q4
$38K Hold
1,347
﹤0.01% 3532
2021
Q3
$61K Buy
+1,347
New +$61K ﹤0.01% 3426
2021
Q2
Sell
-811
Closed -$50K 3488
2021
Q1
$50K Buy
+811
New +$50K ﹤0.01% 3435